In the near future, we will expand these analyses to investigate whether h-Prune has the potential to be developed as diagnostic marker into a population-based screening tool and can be useful for early diagnosis of NSCLC. This evidence concerns the gene PRUNE1 and non-small cell lung carcinoma.